The diagnostic value of RASSF1A promoter methylation in prostate cancer: A systematic review and meta-analysis
s. li, Y.-X. Li, Y. Ye, X.-H. Yuan, J.-J. Wang, H.-L. Yan
This meta-analysis evaluates the diagnostic accuracy of RASSF1A promoter methylation in prostate cancer, finding high specificity and area under the ROC curve.
bioRxiv · Jul 15, 2020 · PreprintCancer Biology